<DOC>
	<DOC>NCT02917174</DOC>
	<brief_summary>Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation, which is a common and frequently occurring disease in the world, and has resulted in a sustained increase of social and economic burden. However, several studies suggest, lots of asthma patients did not get their asthma controlled. The investigators study showed that in China only 28.7% of asthma patients achieve asthma controlled during 2007-2008. In recent years, application softwares of mobile-phones for asthma have gradually increased, studies suggested that application of these application softwares can make treatment more standard, reduce asthma attacks, help patients to control their asthma, improve adherence and these application softwares also show many other advantages. This study is a prospective, multi center, randomized, controlled study, aims to evaluate the efficacy of application softwares in asthma patients, provide a new tool to asthma management.</brief_summary>
	<brief_title>National Mobile Asthma Management System-E Project</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>1.18 years of age or older, having been resided in the same city during the study; 2.A history of at least 3 months of diagnosed asthma based on the criteria established by GINA 2016; need to be on medication containing ICS or ICS/LABA 3.Asthma out patients with ACT scoresï¹¤20 and MARS A mean score &lt; 4.5 ; 4.Owning and Being able to use smart phone that the corresponding software can be successfully installed; 5.Subjects who are willing to participate in the study and sign the informed consent. 1. Unable to communicate properly because of visual impairment, hearing impairment and language barrier, or with mental illness or psychological problems; 2. Have a history of tracheal intubation or mechanical ventilation as a result of acute asthma attack; 3. Have respiratory tract infection within the prior 4 weeks; history of thoracic surgery; with comorbidities such as other/structural lung diseases (COPD, bronchiectasis, lung cancer, et al); heart disease; kidney or autoimmunity disease; or other conditions that could potentially effect asthma control or asthma disease status by investigator's medical opinion. 4. Women with pregnancy, or planned pregnancy within one year.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>asthma</keyword>
	<keyword>m-health</keyword>
	<keyword>asthma control</keyword>
	<keyword>self-management</keyword>
</DOC>